North America Cancer Diagnostics Market Size & Outlook
The cancer diagnostics market in North America is expected to reach a projected revenue of US$ 22,024.0 million by 2033. A compound annual growth rate of 8.3% is expected of North America cancer diagnostics market from 2026 to 2033.
- Clinical Diagnostics
- In Vitro Diagnostics
- Cancer Diagnostics Market Outlook
- In Vitro Diagnostics
Revenue, 2025 (US$M)
$11,578.4
Estimate, 2026 (US$M)
$12,584.1
Forecast, 2033 (US$M)
$22,024.0
CAGR, 2026 - 2033
8.3%
Global Market
Related Markets
GVR research-powered AI
Ask Prism AI about the cancer diagnostics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
North America cancer diagnostics market outlook highlights
- The North America cancer diagnostics market outlook generated a revenue of USD 11,578.4 million in 2025.
- The market is expected to grow at a CAGR of 8.3% from 2026 to 2033.
- In terms of segment, consumables was the largest revenue generating product in 2025.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 11,578.4 million |
| Market revenue in 2033 | USD 22,024.0 million |
| Growth rate | 8.3% (CAGR from 2026 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
| Key market players worldwide | Abbott Laboratories, Roche Holding Ag, Ge Healthcare Technologies Inc Common Stock, Qiagen Nv, Becton Dickinson & Co, Koninklijke Philips Nv, Siemens Healthineers Ag Adr, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 40.5% of the global cancer diagnostics market outlook in 2025. Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 16,880.1 million by 2033.
No credit card required*
Publish Date: Oct 23, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market segmentation & scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
North America Cancer Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cancer Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.85% in 2025.
Horizon Databook has segmented the North America cancer diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2021 to 2033.
- North America Cancer Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Consumables
- Services
- North America Cancer Diagnostics Market Type Outlook (Revenue, USD Million , 2021-2033)
- IVD
- LDT
- Imaging
- North America Cancer Diagnostics Market IVD By Technology Outlook (Revenue, USD Million , 2021-2033)
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Immunohistochemistry (IHC)
- Next-generation Sequencing (NGS)
- Microarrays
- Flow Cytometry
- Immunoassays
- Other IVD Testing Technologies
- North America Cancer Diagnostics Market Application Outlook (Revenue, USD Million , 2021-2033)
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Blood Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
- North America Cancer Diagnostics Market End use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Laboratories
- Others
- North America Cancer Diagnostics Market Test Type Outlook (Revenue, USD Million , 2021-2033)
- Biopsy
- Others
Reasons to subscribe to Cancer Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cancer Diagnostics Market Outlook databook
- Our clientele includes a mix of Cancer Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Cancer Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Cancer Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Cancer Diagnostics Market, 2021-2033 (US$M)
North america cancer diagnostics market statistics, by product 2021 - 2033 (US$M)
